The purpose of this study is to determine whether patients with rheumatoid arthritis and type 2 diabetes experience a more severe disease course compared to control patients with osteoarthritis and type 2 diabetes
Study Type
OBSERVATIONAL
Enrollment
176
AP-HP, Cochin hospital
Paris, Paris, France
Time to the addition of a new treatment for type 2 diabetes in months
addition of a new treatment includes insulin requirement
Time frame: five years
Glycated haemoglobin (HbA1c) levels in %
Time frame: two years
Insulin resistance (HOMA-IR), absolute value
Time frame: two years
Proportion of patients requesting insulin in %
Time frame: two years
Proportion of patients with type 2 diabetes-related acute complications in %
Time frame: two years
Proportion of patients requiring the addition of a new treatment for type 2 diabetes in %
Time frame: five years
Proportion of patients with increased glycated haemoglobin (HbA1c) levels between 2 visits in %
Time frame: five years
Proportion of patients with increased HOMA-IR between 2 visits in %
Time frame: five years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.